KNSA   $21.26  0.81% Market Closed After Close 21.4 0.66%

Kiniksa Pharmaceuticals Ltd
Total Cash 223.78M
totalCashPerShare 3.099
EBITDA -24.40M
Total Debt 10.60M
quickRatio 2.592
currentRatio 3.244
Total Revenue 384.10M
debtToEquity 2.424
Revenue/Share 5.415
ROA -0.03158
ROE -0.021540001
grossProfits
freeCashflow 25.74M
operatingCashflow 11.24M
earningsGrowth
revenueGrowth 0.674
grossMargins 0.61035997
ebitdaMargins -0.06353
operatingMargins -0.08607
profitMargins -0.023610001
enterpriseValue 1.38B
forwardPE 46.06
floatShares 15.29M
sharesOutstanding 41.57M
sharesShort 4.01M
sharesShortPriorMonth 4.64M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.89%
Short Ratio help_outline 8.53%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue 6.056
Price To Book help_outline 3.80
earningsQuarterlyGrowth
netIncomeToCommon -9.07M
trailingEps -0.12%
forwardEps 0.50%
enterpriseToEbitda -56.45
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.01 4Q 2024
institutionsCount 211
lastUpdated Nov. 7, 2024, 2:49 a.m.